We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Matthew Mossanen

Matthew Mossanen MD

Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, Massachusetts

Recent Contributions to PracticeUpdate:

  1. AACR: Combination Checkpoint Inhibitor and Chemotherapy for Advanced Urothelial Carcinoma
  2. Practical Approaches to BCG Unresponsive Bladder Cancer
  3. Integrating Immuno-Oncology and Targeted Therapy for Bladder Cancer in Practice
  4. Smoking Cessation and Bladder Cancer
  5. Atezolizumab and Bevacizumab for Renal Cell Carcinoma With Variant Histology
  6. Management Strategies for Non-Muscle-Invasive Bladder Cancer
  7. Surgical Approaches in Bladder Cancer: Robotic vs Open Cystectomy
  8. Urinary Diversion in Bladder Cancer and Quality-of-Life Considerations
  9. Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer
  10. Use of BCG in Non-Muscle-Invasive Bladder Cancer

Most Read This Week

Recently Updated